Global Endowment Management, LP
EndowmentPosition in APGE — Apogee Therapeutics, Inc.
CIK 1512237
CHARLOTTE, NC
Position in APGE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$656,273
+$67,756 QoQ
Shares Held
7,797
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Global Endowment Management, LP holds $1,076,279 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYRE |
Spyre Therapeutics, Inc.
|
12,123 | $1,076,279 |
All Filings in APGE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $656,273 | 7,797 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $588,517 | 7,797 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $309,774 | 7,797 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $338,623 | 7,797 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $291,295 | 7,797 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $353,204 | 7,797 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $457,995 | 7,797 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $306,811 | 7,797 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $518,110 | 7,797 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||